AGIO Price Target and Analyst Ratings (Agios Pharmaceuticals) Nov 05, 2019 · 12 Wall Street analysts have issued ratings and price targets for Agios Pharmaceuticals in the last 12 months. Their average twelve-month price target is $63.10, suggesting that the stock has a possible upside of 81.84%. The high price target for AGIO is $79.00 and the low price target for AGIO is $49.00. AGIO -- Is Its Stock Price A Worthy Investment? Learn More. AGIO Stock Summary. Of note is the ratio of Agios Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; only 12.53% of US stocks have a lower such ratio. With a price/sales ratio of 26.28, Agios Pharmaceuticals Inc has a higher such ratio than 95.16% of stocks in our set. AGIO - Agios Pharmaceuticals Summary, Stock ... - Benzinga Jan 01, 2010 · Agios Pharmaceuticals (NASDAQ: AGIO) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers Agios Pharmaceuticals (AGIO) Stock: Weak On High Volume Today
Agios Pharmaceuticals - AGIO - Stock Price & News | The ...
In addition, this page includes various stock data for Agios Pharmaceuticals, such as the latest Agios Pharmaceuticals stock price history, total returns, stock price today in addition to fundamental data such as earnings and dividends as well as valuation measures such as dividend yield and PE ratio. Agios Pharmaceuticals Stock Quote: AGIO Stock News, Quotes ... Nov 06, 2019 · AGIO, Agios Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Agio Paper & Industries share price by 0.00% - Why is Agio ... Agio Paper & Industries Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 4.03 Crore) operating in Paper sector. Agio Paper & Industries Ltd. key Products/Revenue Segments include for the year ending 31-Mar-2018. AGIO Historical Stock Prices
Get Agio Paper & Industries Live NSE/BSE Share Price and Stock Price today along with detailed News, Financial Results, Stock Charts, Returns, Research Reports and more.
Agios A Buy On Stock Price Retreat, Cholangiocarcinoma ... Jun 19, 2019 · Agios Pharmaceuticals is a commercial-stage biotechnology company specializing in targeted cancer therapies.Its Tibsovo drug for acute myeloid leukemia went on the market after FDA approval in 2018.